| Code: MTA12980 | Publication Date: Jun 2026 |
The South Korea Ketoconazole Market is witnessing steady growth, driven by the historical existence of advanced domestic pharma companies, in addition to a well-established healthcare framework. Ketoconazole is an essential antifungal drug which has significant market value, owing to its wide application in dermatological treatments, specifically seborrheic dermatitis.
For detailed forecasts, data tables, and competitive benchmarking,
Explore the full South Korea Ketoconazole Market.
According to 6Wresearch, the South Korea Ketoconazole market is anticipated to witness substantial growth, on account of the rising incidences of fungal skin disorders, growing elderly population with the need for continued dermatology treatment, and modernized clinics and hospitals in the region.
The requirement for effective and stable anti-fungal drugs is motivating companies to increase the accuracy of manufacturing and supply chain logistics. Moreover, the search for affordable generics is driving a highly competitive industry, where R&D abilities and understanding of retail pharmacies are essential factors of success.
The competitive landscape of the South Korea Ketoconazole Industry is defined by the commitment to high quality production, and superior medical efficacy. The market flourishes on the basis of an intricate structure involving regional organizations and logistics companies with international operations. The key growth factors driving the market involve the implementation of PIC/S GMP production standards, continuous integration in the National Health Insurance drug formulary, and strict compliance with the Korean Ministry of Food and Drug Safety.
Below is a list of leading players operating in the South Korea Ketoconazole Market:
| Company Name | Korea Pharma Co., Ltd. |
|---|---|
| Established Year | 1974 |
| Headquarters | Seoul, South Korea |
| Official Website | Click Here |
Korea Pharma specializes in highly stable dermatological formulations, ensuring consistent therapeutic results for widespread clinical use.
| Company Name | Hanmi Pharmaceutical |
|---|---|
| Established Year | 1973 |
| Headquarters | Seoul, South Korea |
| Official Website | Click Here |
Hanmi leverages its smart-factory infrastructure to produce high-purity antifungal agents for both domestic and international markets.
| Company Name | Yuhan Corporation |
|---|---|
| Established Year | 1926 |
| Headquarters | Seoul, South Korea |
| Official Website | Click Here |
Yuhan maintains a vast distribution network that ensures essential antifungal medications reach primary care facilities nationwide.
| Company Name | JW Pharmaceutical |
|---|---|
| Established Year | 1945 |
| Headquarters | Seoul, South Korea |
| Official Website | Click Here |
JW provides reliable antifungal solutions that are a staple in Korean hospital pharmacies.
| Company Name | Daewoong Pharmaceutical |
|---|---|
| Established Year | 1966 |
| Headquarters | Seoul, South Korea |
| Official Website | Click Here |
Daewoong focuses on therapeutic precision, providing advanced ketoconazole-based topical treatments that meet the high standards of dermatologists.
| Company Name | Dong-A ST |
|---|---|
| Established Year | 1932 |
| Headquarters | Seoul, South Korea |
| Official Website | Click Here |
Dong-A ST utilizes its extensive expertise in metabolic and dermatological medicine to support the supply of stable, effective antifungal formulations.
| Company Name | Celltrion Pharm |
|---|---|
| Established Year | 2002 |
| Headquarters | Cheongju, South Korea |
| Official Website | Click Here |
Celltrion Pharm focuses on utilizing its high-standard manufacturing capabilities to provide safe, affordable, and high-quality generic therapeutic agents.
| Company Name | Samchundang Pharm |
|---|---|
| Established Year | 1943 |
| Headquarters | Hwaseong, South Korea |
| Official Website | Click Here |
Samchundang provides essential antifungal agents that are highly accessible through retail and hospital channels.
| Company Name | Astellas Pharma Korea |
|---|---|
| Established Year | 2005 |
| Headquarters | Tokyo, Japan (Global) / Seoul, South Korea |
| Official Website | Click Here |
Astellas supports the Korean market with premium, evidence-based antifungal therapeutic solutions.
| Company Name | Viatris Korea |
|---|---|
| Established Year | 2020 (Launch) |
| Headquarters | Canonsburg, USA (Global) / Seoul, South Korea |
| Official Website | Click Here |
Viatris focuses on bridging the gap in healthcare access by providing broad, sustainable availability of quality-assured antifungal medications.